Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > 150?

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Jul 05, 2023 10:30am

226 Views

Post# 35527231

150?

I'll go on record with a guess

Assuming 90 by Early December ( see previous post)

And a pace which should be 7 enrollees per month with 25 Sites (.28 /site/month) by then...

An extra 60 ( 150-90) are needed to reach 150, which should take roughly 8.5 months ( 60/7) from early December 2023, or roughly July 2024.

So summer 2024, or mid-year 2024.

But well before then, investors should be able to predict/ calculate ultimate approval odds, Baxter backing, and calculate with more certainty, the extreme under-valuation.

MM

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit